B7-1 cancer vaccine

N/A

Report date: 2023/02/17 21:17:32

Base Information

Drug NameB7-1 cancer vaccine
Drug Alias NameN/A
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsOvarian NeoplasmsPancreatic NeoplasmsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesKing'S College LondonNational Cancer Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesKing'S College LondonNational Cancer Institute +[3] 
Active IndicationsN/A
Inactive IndicationsOvarian NeoplasmsPancreatic NeoplasmsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A
Related LinksN/A